2 results match your criteria: "University Hospital Center Zagreb and Zagreb Medical School[Affiliation]"
Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.
Pathol Oncol Res
July 2015
Department of Medical Oncology, Division of Oncology, University Hospital Center Zagreb and Zagreb Medical School, Kišpatićeva 12, HR- 10 000, Zagreb, Croatia,
HER-2/neu extracellular domain (ECD) can be detected in blood as a soluble circulating protein. The aim of this study was to analyze the relationship between HER-2/neu extracellular domain in the serum and the prognosis in breast cancer patients. We also correlated HER-2/neu ECD with various clinicopathological factors including steroid receptor, HER-2/neu receptor coexpression.
View Article and Find Full Text PDFLow serum MMP-1 in breast cancer: a negative prognostic factor?
Biomarkers
August 2012
Department of Pathophysiology, University Hospital Center Zagreb and Zagreb Medical School, Zagreb, Croatia.
In this study we investigated the prognostic significance of serum matrix metalloproteinase (MMP)-1 levels in early-stage breast cancer patients and correlated these levels with various clinicopathologic parameters. MMP-1 levels were determined by enzyme-linked immunosorbent assay. MMP-1 serum levels in patients (n = 60) were significantly lower than in healthy subjects (n = 20, p < 0.
View Article and Find Full Text PDF